Research Options:

Week of Expected Pricing Withdrawn
Company Name Endostim, Inc.
Proposed Ticker STIM
CUSIP 29272M101
Business Description A medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.
Lead Underwriter Wedbush PacGrow Life Sciences
Co-Managers Craig-Hallum Capital Group LLC, Roth Capital Partners, Inc
Initial Shares 32,00,000
Revised Initial Shares N/A
Initial Price $10.00-$12.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.